JNJ

Johnson & Johnson
D

JNJ

Arincen70/100B

Johnson & Johnson return on equity (ROE)

Johnson & Johnson's return on equity is 19.74%: net income of 16.10B USD over the last twelve months on shareholders' equity of 81.53B USD.

Today
19.74%
Average, 5 years
24.02%
Low, 5 years
17.37%
High, 5 years
32.87%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 16.10B ÷ 81.53B = 19.74%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

Why is Johnson & Johnson's return on equity so high?

Net margin
28.5%
profit on each dollar of sales
Asset turnover
0.47×
sales on each dollar of assets
Equity multiplier
2.44×
assets on each dollar of equity
Return on equity
32.9%
FY2025
  • FY202528.5% × 0.47 × 2.44 = 32.9%
  • FY202415.8% × 0.49 × 2.52 = 19.7%
  • FY202341.3% × 0.51 × 2.44 = 51.1%
  • FY202222.4% × 0.43 × 2.44 = 23.4%
  • FY202126.5% × 0.43 × 2.46 = 28.2%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today19.74%16.10B81.53B
FY202528 Dec 202532.87%26.80B81.54B
FY202429 Dec 202419.68%14.07B71.49B
FY202331 Dec 202319.38%13.33B68.77B
FY20221 Jan 202323.36%17.94B76.80B
FY20212 Jan 202228.20%20.88B74.02B
FY20203 Jan 202123.25%14.71B63.28B
FY201931 Dec 201925.42%15.12B59.47B
FY201831 Dec 201825.60%15.30B59.75B
FY201731 Dec 20172.16%1.30B60.16B
FY201631 Dec 201623.49%16.54B70.42B
FY201531 Dec 201521.66%15.41B71.15B
FY201431 Dec 201423.40%16.32B69.75B
FY201331 Dec 201318.68%13.83B74.05B
FY201231 Dec 201216.22%10.51B64.83B
FY201131 Dec 201116.94%9.67B57.08B
FY201031 Dec 201023.57%13.33B56.58B
FY200931 Dec 200924.25%12.27B50.59B
FY200831 Dec 200830.46%12.95B42.51B
FY200731 Dec 200724.41%10.58B43.32B
FY200631 Dec 200628.11%11.05B39.32B
FY200531 Dec 200526.89%10.41B38.71B
FY200431 Dec 200426.75%8.51B31.81B
FY200331 Dec 200326.79%7.20B26.87B
FY200231 Dec 200229.07%6.60B22.70B
FY200131 Dec 200123.39%5.67B24.23B
FY200031 Dec 200023.54%4.80B20.40B
FY199931 Dec 199925.70%4.17B16.21B
FY199831 Dec 199821.73%3.06B14.08B
FY199731 Dec 199726.73%3.30B12.36B
FY199631 Dec 199626.64%2.89B10.84B
FY199531 Dec 199526.57%2.40B9.05B
FY199431 Dec 199428.17%2.01B7.12B
FY199331 Dec 199332.09%1.79B5.57B
FY199231 Dec 199231.43%1.63B5.17B
FY199131 Dec 199125.97%1.46B5.63B
FY199031 Dec 199023.33%1.14B4.90B
FY198931 Dec 198926.08%1.08B4.15B
FY198831 Dec 198827.80%974.00M3.50B
FY198731 Dec 198723.90%833.00M3.49B
FY198631 Dec 198611.67%329.50M2.82B
FY198531 Dec 198518.31%613.70M3.35B

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Johnson & Johnson's ROE

Source: Financial Modeling PrepVerified against SEC filings